Vasopressin and cardiovascular autonomic adjustment in chronic hypertensive pregnancy.

Autor: Jovanović M; Department of Pathophysiology, University of Belgrade Faculty of Medicine, Belgrade, RS, Serbia., Stevanović B; University of Belgrade Faculty of Dentistry, Belgrade, RS, Serbia., Pajović V; Department of Pharmacology, University of Belgrade Faculty of Medicine, Belgrade, RS, Serbia., Tasić T; University of Belgrade Faculty of Dentistry, Belgrade, RS, Serbia., Lozić M; Department of Pharmacology, University of Belgrade Faculty of Medicine, Belgrade, RS, Serbia., Đukić L; University of Belgrade Faculty of Dentistry, Belgrade, RS, Serbia., Kosić M; Department of Pharmacology, University of Belgrade Faculty of Medicine, Belgrade, RS, Serbia., Murphy D; Bristol Medical School: Translational Health Sciences, University of Bristol, Bristol, UK., Japundžić-Žigon N; Department of Pharmacology, University of Belgrade Faculty of Medicine, Belgrade, RS, Serbia. nina.japundzic@gmail.com.
Jazyk: angličtina
Zdroj: Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2024 Sep; Vol. 47 (9), pp. 2393-2404. Date of Electronic Publication: 2024 Jul 22.
DOI: 10.1038/s41440-024-01769-6
Abstrakt: Chronic hypertensive pregnancy (CHP) is a growing health issue with unknown etiology. Vasopressin (VP), a nonapeptide synthesized in paraventricular (PVN) and supraoptic nucleus (SON), is a well-known neuroendocrine and autonomic modulator of the cardiovascular system, related to hypertension development. We quantified gene expression of VP and its receptors, V1aR and V1bR, within the PVN and SON in CHP and normal pregnancy, and assessed levels of secreted plasma VP. Also, we evaluated autonomic cardiovascular adaptations to CHP using spectral indices of blood pressure (BPV) and heart rate (HRV) short-term variability, and spontaneous baroreflex sensitivity (BRS). Experiments were performed in female spontaneously hypertensive rats (SHRs) and in normotensive Wistar rats (WRs). Animals were equipped with a radiotelemetry probe for continuous hemodynamic recordings before and during pregnancy. BPV, HRV and BRS were assessed using spectral analysis and the sequence method, respectively. Plasma VP was determined by ELISA whilst VP, V1aR, and V1bR gene expression was analyzed by real-time-quantitative PCR (RT-qPCR). The results show that non-pregnant SHRs exhibit greater VP, V1aR, and V1bR gene expression in both PVN and SON respectively, compared to Wistar dams. Pregnancy decreased VP gene expression in the SON of SHRs but increased it in the PVN and SON of WRs. Pregnant SHRs exhibited a marked drop in plasma VP concentration associated with BP normalization. This triggered marked tachycardia, heart rate variability increase, and BRS increase in pregnant SHRs. It follows that regardless of BP normalization in late pregnancy, SHRs exhibit cardiovascular vulnerability and compensate by recruiting vagal mechanisms. Pregnant SHR dams have reduced expression of VP in SON associated with increased V1bR expression, lower plasma VP, normal BP during late pregnancy and marked signs of enhanced sympathetic cardiac stimulation (increased HR and LFHR variability) and recruitment of vagal mechanisms (enhancement of BRS and HFHR variability).
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: